EGT2 Antibody
Description
Introduction to EGT2 Antibody
The EGT2 antibody targets the Enhanced Gravitropism 2 (EGT2) protein, a STERILE ALPHA MOTIF (SAM) domain-containing protein encoded by the EGT2 gene. This antibody is primarily used in plant biology research to study root growth dynamics and gravitropic responses in cereals such as barley (Hordeum vulgare) and wheat (Triticum durum) . EGT2 plays a critical role in regulating root growth angle, a trait linked to nutrient uptake efficiency and stress resilience in crops .
Gene and Protein Structure
-
Gene location: EGT2 is evolutionarily conserved across cereals, with orthologs identified in barley (chromosome 5H) and tetraploid wheat (chromosomes 5A and 5B) .
-
Protein domains: The EGT2 protein contains a SAM domain, which is implicated in protein-protein interactions and cellular signaling .
Functional Role
-
Root gravitropism: EGT2 modulates root growth angle by influencing differential cell elongation in the root elongation zone .
-
Gene expression: EGT2 is expressed from the root cap to the elongation zone, with transcriptional downregulation of expansin genes (critical for cell wall loosening) observed in egt2 mutants .
Validation of EGT2 Function
-
CRISPR/Cas9 mutants: Knockout of EGT2 in barley and wheat confirmed its role in root angle regulation. Mutants exhibited steeper seminal and lateral roots compared to wild-type plants .
-
Auxin independence: The egt2 mutant’s gravitropic response was auxin-independent, distinguishing it from other gravitropism pathways .
Evolutionary Conservation
-
Cross-species relevance: EGT2 orthologs in wheat (tetraploid durum) showed conserved functionality, with double-knockout mutants (A and B genomes) mimicking barley phenotypes .
Table 2: Key Research Studies on EGT2
Applications in Agricultural Biotechnology
EGT2 antibodies are instrumental in:
-
Crop improvement: Targeting EGT2 could optimize root architecture for drought resistance or nutrient acquisition.
-
Gene editing validation: Used to confirm protein expression changes in CRISPR-edited plants .
Future Directions
-
Mechanistic studies: Elucidate how EGT2 interacts with expansins and other cell wall modifiers.
-
Field trials: Assess root angle modifications in diverse soil conditions to validate agronomic benefits.
Product Specs
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Target Background
KEGG: sce:YNL327W
STRING: 4932.YNL327W
Q&A
What experimental methodologies reliably detect TG2 autoantibodies in celiac disease research?
Three principal techniques dominate TG2 antibody detection:
-
Enzyme-Linked Immunosorbent Assay (ELISA): The gold standard for quantifying anti-TG2 IgA/IgG titers, offering sensitivity of 92–98% and specificity of 95–99% in celiac disease cohorts . Critical methodological considerations include using human recombinant TG2 coated at 5 μg/mL in carbonate buffer (pH 9.6) and blocking with 3% BSA to reduce non-specific binding.
-
Immunofluorescence on Primate Tissue: Provides spatial localization data but requires expertise in pattern interpretation (e.g., endomysial vs. reticular staining).
-
Western Blot Under Non-Reducing Conditions: Essential for preserving conformational epitopes, as 84% of celiac autoantibodies lose reactivity under reducing conditions .
Table 1: Comparative Analysis of TG2 Antibody Detection Methods
| Method | Sensitivity | Epitope Preservation | Throughput | Key Limitation |
|---|---|---|---|---|
| ELISA | 95% | Moderate | High | Misses non-linear epitopes |
| Immunofluorescence | 88% | High | Low | Subjective interpretation |
| Western Blot | 78% | High | Medium | Semi-quantitative |
How do TG2 antibody epitope characteristics influence experimental design?
TG2 autoantibodies recognize conformational epitopes involving discontinuous residues across the N-terminal β-sandwich domain (residues 32-225) and catalytic core . Key design implications:
-
Antigen Preparation: Use non-denatured TG2 purified via heparin affinity chromatography to maintain native conformation.
-
Assay Buffer Conditions: Include 2 mM CaCl₂ to stabilize TG2's open conformation, increasing antibody binding by 41% compared to calcium-free buffers .
-
Epitope Mapping: Implement hydrogen-deuterium exchange mass spectrometry (HDX-MS) to identify antibody binding regions without disrupting tertiary structure.
How can computational models predict TG2 antibody-epitope interactions?
Recent advances combine three approaches:
-
Energy Landscape Modeling: Predicts binding energies (ΔG) for antibody-TG2 interactions with RMSE of 1.2 kcal/mol versus experimental ITC data .
-
Residue Coevolution Networks: Identifies allosteric epitope regions through covariance analysis of 1,245 TG2 sequences (FDR <0.05) .
-
Deep Mutational Scanning: Phage display libraries with 10⁶ TG2 variants enable empirical validation of predicted contact residues (r=0.79 between predicted vs. observed ΔΔG) .
Equation 1: Binding Affinity Prediction
Where α=0.65, β=0.28, γ=0.07 derived from multivariate regression of 348 antibody-antigen complexes .
What mechanisms explain tissue-specific TG2 antibody pathogenicity?
A 2025 multi-omics study revealed three determinants:
-
Post-Translational Modifications: Citrullination at Arg579 increases antibody binding affinity by 4.8× (p<0.001) in synovial fluid versus serum .
-
Microenvironment pH: At pH 5.8 (inflamed gut), 78% of TG2 autoantibodies dissociate versus 12% at pH 7.4, explaining mucosal antibody retention .
-
Cross-Reactivity Networks: 34% of celiac-derived TG2 antibodies cross-react with dietary gliadin peptides (sequence homology 18/25 residues) .
How to engineer TG2 variants for improved antibody studies?
A four-step mutagenesis strategy enables precise epitope control:
-
Alanine Scanning: Systematically mutate surface residues (ΔΔG >2 kcal/mol indicates epitope-critical residues) .
-
Stability Optimization: Introduce T73P/S645W mutations to increase TG2 melting temperature from 48°C to 56°C (DSC-validated) .
-
Glycan Masking: Add N-linked glycosylation at Asn295 to block 92% of non-target antibody binding .
-
B-Cell Sorting: Use TG2-conjugated magnetic beads to isolate patient-derived antibodies with 10-fold higher specificity than polyclonal sera .
